Harvard Men's Health Watch

Immunotherapy: A new option for advanced prostate cancer

Men with advanced prostate cancer that has started growing again after androgen-deprivation therapy may benefit from a new immunotherapy treatment.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In